Epinephrine, also known as Adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
Seattle, WA -- (SBWIRE) -- 11/26/2019 -- Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism. Epinephrine is used as a vasoconstrictor in shock, as a stimulant during cardiac arrest and as an antispasmodic and bronchodilator in bronchial asthma.
For More Info and for a Sample Copy: https://www.worldwidemarketreports.com/sample/141343
During cardiac arrest, there is a need for maximum amount of blood flow in the coronary artery and this is facilitated when epinephrine is injected into an intravenous solution. Epinephrine has effects on various parts of the body such as liver, skin, heart and lungs. For instance, in lungs epinephrine causes the relaxation of smooth muscles of lungs. Patients suffering from asthma have constricted lung passages that are prone to inflammation and swelling.
Epinephrine injections are commonly used against life threatening allergic reactions caused by medications, insect bites and stings. Epinephrine injections are available as prefilled automatic injection device with the hormone in the liquid form. Epinephrine is a class of medications called as alpha and beta adrenergic agonists and these medications work by tightening the blood vessels and by relaxing the muscles in the airways.
The market for epinephrine auto-injector market exhibits tremendous growth potential owing to several technological advances towards development of innovative epinephrine injectors. Epinephrine auto injectors market can be analyzed on the basis of the product penetration and availability across the four major geographical regions namely North America, Europe, Asia-Pacific and RoW.
Some of the major factors favoring the growth of this market are increasing number of patient population susceptible to several allergic reactions along with increased focus of the market players towards development of chlorofluorocarbon (CFC) free epinephrine auto-injectors. This is majorly due to the ban on the use of CFC as a propellant inhaler by the U.S. Government.
In addition, continuous product modifications, increased need and demand of automatic injection devices further propel the growth and development of epinephrine auto injectors market. On the contrary, the side effects caused by epinephrine medications pose a challenge to the growth of the market. The Key Market Players operating in this market are Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC and ALK Abello A/S.
Place an Enquiry For Complete List of Key Players: https://www.worldwidemarketreports.com/quiry/141343
Market Segment by Type, covers
Epinephrine Prefilled Syringe
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Epinephrine market.
Chapter 1, to describe Epinephrine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyse the top manufacturers of Epinephrine, with sales, revenue, and price of Epinephrine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Epinephrine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyse the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Epinephrine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Epinephrine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source